Company news
Sihuan Pharmaceutical Holdings Group Ltd. news in 2021
Sihuan Pharmaceutical Holdings Group Ltd.'s news releases, calls and decks from 2021, newest first.
Voluntary announcement - insulin aspart 30 injection developed by Sihuan Pharmaceutical achieved equivalent clinical results in efficacy and safety study as originator drug
July 30, 2021
Voluntary announcement-entering into strategic cooperation agreement between jilin huisheng biopharmaceutical and porton pharma
April 28, 2021
Voluntary announcement - share repurchase
April 9, 2021
Voluntary announcement-Sihuan Pharmaceutical obtained drug registration approval in relation to ambroxol hydrochloride injection
April 1, 2021
Voluntary announcement proposed share repurchase under the general mandate
March 28, 2021
Voluntary announcement Sihuan Pharmaceutical obtained drug registration approval in relation to rivaroxaban tablets
March 25, 2021
Sihuan Pharmaceutical Holdings Group: Voluntary announcement the group's liraglutide has completed phase i clinical study for indication of weight loss
February 25, 2021